Valeant shares dive despite CEO's return from illness

Shares of Valeant Pharmaceuticals are down sharply in morning trading Monday, amid ongoing turmoil over the embattled drugmaker's delayed financial results and its leader's health.

See Full Article

Even news Sunday that CEO Michael Pearson is returning immediately after nine weeks recovering from pneumonia and unspecified complications failed to buoy Valeant shares.

The shares are trading at less than one-third of their $263.81 high last August. That was right before Valeant's practice of buying rights to old drugs and jacking up the prices came under congressional scrutiny, and a few months before its questionable relationship with a drug distributor raised concerns about the accuracy of its financial reporting.

Valeant shares dropped $6.75, or 8.4 per cent, to $73.90 in midday trading Monday.

Investors appear to be reacting to Valeant's announcement in a statement Sunday that is withdrawing all its financial forecasts.

Nomura equity analyst Shibani Malhotra wrote Monday that while Pearson's return to the helm "is a positive," for the company, she's concerned by Valeant's decision to withdraw its 2016 guidance, which was confirmed just six weeks ago.

Valeant, based in Laval, Quebec, also again delayed announcing its preliminary fourth-quarter and 2015 financial results, which were to be released Monday. The company cited Pearson's return to work as the reason.

"Valeant won't turn around until it restores its credibility, and it doesn't help to bring back the CEO who created the questions about financial reporting on his watch and his handling of questions about Philidor," Erik Gordon, a professor and pharmaceuticals analyst at University of Michigan's Ross School of Business, wrote in an email.

Pearson's convalescence, and the limited information the company released about his condition, aren't the only concerns dragging down Valeant shares.

Last Tuesday, Valeant said it would delay filing its 2015 annual report with regulators while it sorts out its former relationship with the mail-order pharmacy Philidor. Valeant said it expected to lower reported 2014 earnings by about 10 cents per share and raise 2015 earnings by about 9 cents. That's because about $58 million in sales to Philidor were improperly recognized too early -- when they were delivered to Philidor, rather than when patients received the products.

Moody's Investor's Service on Tuesday revised Valeant's outlook to negative from stable, but noted that the amount of revenue misstated "appears relatively minor."

Valeant cut ties with Philidor last fall amid allegations that Philidor created a network of "phantom pharmacies" to steer pharmacy benefit managers toward Valeant's more-expensive drugs instead of cheaper alternatives.

Responding to public criticism over its huge price increases for some products, Valeant's interim CEO, Howard Schiller, on Feb. 2 told a House committee investigating high drug prices that he froze all of Valeant's price increases when he took over in January. He said Valeant would aim for more modest price increases in the future.

Schiller is to transition out of his temporary CEO duties but remain a member of Valeant's board. The board also decided to split the roles of chairman and CEO, both of which had been held by Pearson, and appoint Robert A. Ingram as chairman of the board. Ingram has been on Valeant's board since 2010 and previously served as chairman for a few months at the start of 2011.

The board said in the statement that planning for Pearson's successor and expanding Valeant's senior management "are high priorities."

Jeffrey Loo, equity analyst at S&P Global Market Intelligence, wrote Monday that "the return of Mr. Pearson and (Valeant's) efforts to build out its management team for succession planning should provide some stability" and that he maintains a "Buy" recommendation on the stock.



Advertisements

Latest Economic News

  • Loonie, TSX lower; U.S. stock markets closed

    Economic CTV News
    TORONTO -- The Canadian dollar and Toronto Stock Exchange were lower in late-morning trading, with key U.S. markets closed for a holiday. The S&P/TSX composite index dropped 50.54 points at 15,446.74 after nearly two hours of trading. Source
  • Hard Brexit details send British pound to hard landing under $1.20 US

    Economic CBC News
    The British pound fell to its lowest since 1985 on Monday after speculation ramped up that British Prime Minister Theresa May will lay out her plans for a so-called "hard Brexit" from the EU to European lawmakers tomorrow. Source
  • IMF expects Canada's economy to expand by 1.9% this year

    Economic CBC News
    The International Monetary Fund is projecting strengthening world growth in 2017 and has upgraded its estimates of Canada's economic potential. However the Washington-based agency says any moves by the incoming Donald Trump administration to restrict trade could dampen the improving outlook. Source
  • Home sales rebound in December after large drop in November: CREA

    Economic CTV News
    TORONTO -- The Canadian Real Estate Association says home sales climbed 2.2 per cent in December compared with November as they recovered from a dip following the introduction of new mortgage rules. On a year-over-year basis, the real estate association says home sales were down five per cent last month compared to December 2015. Source
  • IMF: Canada will outpace most G-7 economies in 2017-2018

    Economic CTV News
    WASHINGTON, Wash. - The International Monetary Fund says uncertainty surrounding the incoming Donald Trump administration in the United States is making it difficult to forecast how the global economy will perform this year. But the Washington-based IMF says it estimates the Canadian economy will grow by 1.9 per cent in 2017 and 2.0 per cent in 2018. Source
  • IMF: Canada will outpace most G7 economies in 2017-2018

    Economic CTV News
    WASHINGTON, Wash. - The International Monetary Fund says uncertainty surrounding the incoming Donald Trump administration in the United States is making it difficult to forecast how the global economy will perform this year. But the Washington-based IMF says it estimates the Canadian economy will grow by 1.9 per cent in 2017 and 2.0 per cent in 2018. Source
  • OPEC cuts, while the U.S. turns on the oil taps

    Economic CBC News
    It's been a few weeks since members of OPEC started cutting production. Saudi Arabia said last Wednesday that its production is the lowest it's been in two years, Iraq said that it had made cuts, as did Kuwait. Source
  • Stark inequality: Oxfam says 8 men as rich as half the world

    Economic CTV News
    DAVOS, Switzerland -- The gap between the super-rich and the poorest half of the global population is starker than previously thought, with just eight men, from Bill Gates to Michael Bloomberg, owning as much wealth as 3.6 billion people, according to an analysis by Oxfam released Monday. Source
  • Who are the 8 richest people? All men, mostly Americans

    Economic CTV News
    DAVOS, Switzerland -- The eight individuals who own as much as half of the rest of the planet are all men, and have largely made their fortunes in technology. Most are American, with one European and one Mexican in the mix. Source
  • German ministers reject Trump remarks on car tariffs

    Economic CTV News
    BERLIN -- Senior German officials reacted with surprise and defiance Monday to comments made by President-elect Donald Trump, who said in an interview that NATO was "obsolete" and threatened Germany's automakers with hefty import taxes. Source